Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 206 publications
Unique Aspects of Allogeneic Hematopoietic Stem Cell Transplantation in VEXAS Syndrome: One Size Does Not Fit All.
Journal: American journal of hematology
Published: July 18, 2026
Older Age, STAG2, and DNMT3A Mutations Predict Superior Posttransplant Survival in Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents.
Journal: American journal of hematology
Published: July 11, 2026
Determinants of survival after failure of frontline venetoclax plus hypomethylating agent therapy in 356 patients with newly diagnosed acute myeloid leukemia.
Journal: Blood cancer journal
Published: May 27, 2026
Acute Myeloid Leukemia Subtype-Specific Prognostic Value of NGS in the Setting of Intensive Chemotherapy.
Journal: American journal of hematology
Published: May 13, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents.
Journal: American journal of hematology
Published: May 12, 2026
Extended Cancer Spectrum in Adults With Telomere Biology Disorders: Insights From a 113-Patient Single-Center Cohort.
Journal: American journal of hematology
Published: May 08, 2026
Promoter TERT-Related Hematopoietic Somatic Mosaicism in Patients With Telomere Biology Disorders.
Journal: American journal of hematology
Published: April 22, 2026
Ontogeny and Natural History of Therapy-Related Clonal Hematopoiesis From a Multidisciplinary CHIP Clinic.
Journal: American journal of hematology
Published: March 06, 2026
CHIP clinics: a practical overview of structure and function.
Journal: Blood cancer journal
Published: March 04, 2026
Characteristics of clonal cytopenia of undetermined significance in the presence of ZRSR2 mutations.
Characteristics of clonal cytopenia of undetermined significance in the presence of ZRSR2 mutations.
Journal: Haematologica
Published: February 26, 2026
Dynamic-EASIX DRI Model: A Novel Tool for Predicting Outcomes After Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: February 08, 2026
Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma.
Journal: Blood cancer journal
Published: January 15, 2026
Last Updated: 09/26/2026